At a glance
- Originator Abbott Laboratories
- Developer Abbott Laboratories; Takeda; TAP Pharmaceutical Products
- Class Antineoplastics
- Mechanism of Action Gonadotropin releasing hormone inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Female infertility; Male infertility; Prostate cancer